Glucagon-Like Peptide-1 Receptor Agonist Eligibility Among US Adolescents and Young Adults

Key Points

• A significant number of US adolescents and young adults are eligible for GLP-1RA treatment, highlighting a need for targeted therapeutic strategies.
• Demographic, clinical, and socioeconomic factors influence eligibility for GLP-1RAs, with the study providing essential insights into these characteristics.
• The analysis employed a cross-sectional design to assess eligibility criteria, revealing important gaps in awareness and access to GLP-1RAs for youth populations.
• Understanding eligibility factors may enable healthcare providers to better address the needs of adolescents and young adults requiring intervention.